Skip to main content
SI

StimuSIL, Inc.

The startup develops proprietary devices for subdermal photobiomodulation, utilizing patented technology to penetrate the melanin layer for effective therapy. This approach enables medical professionals to deliver safe and targeted photobiomodulation treatment, addressing the limitations of traditional methods.

Wilmington, United States9100+ followers
Updated 2 months ago

Funding

$9.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Traditional photobiomodulation therapies for dermatological and aesthetic applications face limitations due to light scattering and absorption by the melanin layer of the skin, reducing the effectiveness of surface-level treatments. This can lead to inconsistent results and the need for higher energy levels, potentially causing unwanted side effects.

Solution

StimuSIL is developing medical devices that utilize proprietary methods for subdermal photobiomodulation, delivering light-based energy directly beneath the skin's surface. Their patented technology aims to bypass the melanin layer, allowing for more precise and efficient stimulation of biological pathways. This approach seeks to enhance the biostimulatory effects of photobiomodulation while minimizing energy loss and potential skin damage. StimuSIL's lead candidate is a medical device for androgenetic alopecia, with ongoing research and development for other aesthetic and dermatological indications.

Target Audience

The primary target audience includes medical professionals in dermatology and aesthetics seeking more effective and safer photobiomodulation therapies, as well as individuals seeking solutions for androgenetic alopecia and other skin conditions.

Features

  • Patented technology for subdermal delivery of photobiomodulation.
  • Targeted stimulation of biological pathways beneath the melanin layer.
  • Medical device for androgenetic alopecia (lead candidate).
  • Research and development pipeline for vitiligo, psoriasis, wrinkles, cellulite, and acne scars.
This profile is AI-generated and may contain inaccuracies.